Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$9.8M
2 rounds on record
Latest round
$3.4M
Venture round · Jun 2024 · 2 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
28 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 7, 2024 Raised a round Venture round $3.4M · SEC Form D Jun 2, 2022 Raised a round Venture round $6.4M · SEC Form D 2021 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jun 2024 $3.4M — SEC Form D
Venture round Jun 2022 $6.4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Genvax Technologies, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Joel HarrisExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Curevo Vaccine51-200 employees
Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation adjuvanted subunit vaccines to the market…
Gamgee is developing personalised mRNA vaccines as a cancer treatment for dogs, built from each dog’s tumour. See how it works with vets…
ReNewVax logoVenture round · 9 mo ago • Founded 2022
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
Animal Vaccine Delivery in Just 30 Minutes. Experience the world's fastest vaccine delivery. Get a complete range of vaccines delivered…
Thyreos Vaccines1-10 employees
Thyreos develops herpesvirus vaccines and vaccine vectors for the animal health and human health markets. Thyreos vaccines are based on a…
TareBio develops vaccines for cancer and infectious diseases by decoding immune responses to engineer targeted antigens.

Overview

Genvax Technologies is an animal vaccine company developing next-generation mRNA + nanoparticle vaccines from Ames, Iowa. Our mission is to deliver faster, more effective vaccines that help protect animal health and strengthen the global food supply.

People

Joel Harris
Executive Officer, Director
DL Hank Harris
Director
Trent Torrance
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Ames United States
HQ
10-50 est. staff
2503 S. Loop Drive, STE 5446, Ames, IA, 50010-8641, US
company site

Financials

Total raised
$9.8M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $3.4M Details
Venture - Series Unknown 2022 $6.4M Details